NextBio Enterprise licensed by University of Southern California for research use

NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, announced that the University of Southern California (USC) has licensed NextBio Enterprise for research use by students and faculty. The University plans to promote use of the NextBio research platform campus-wide beginning in August.

“USC is one of America's leading research institutions, with collaborative initiatives in fields such as Clinical & Translational Health Sciences, Human Health and Neuroscience, among others- all fields that will benefit from NextBio's ability to facilitate searching, discovering and sharing knowledge”

NextBio already offers academic institutions access to its large collection of continuously curated genomic data and enhanced data and literature search functions, but the NextBio Enterprise platform provides additional functionality and support for cross-disciplinary collaboration and translational research. NextBio's Vice President of Engineering, Satnam Alag explains, "USC users of NextBio Enterprise can access our APIs, import unlimited amounts of their own data, and interpret it in the context of our semantically integrated library to make novel insights. As with all NextBio Enterprise users, we offer them hands-on support and training sessions to make the most of our technology for their research."

Using vertical apps like Body Atlas and Pharmaco Atlas, researchers can make relevant correlations between their own results and existing genomic data for multiple tissues, compounds, diseases and more. "This functionality is essential to an institution like USC that emphasizes cross-disciplinary collaboration and the translation of discoveries into meaningful practice," says Satnam.

"USC is one of America's leading research institutions, with collaborative initiatives in fields such as Clinical & Translational Health Sciences, Human Health and Neuroscience, among others- all fields that will benefit from NextBio's ability to facilitate searching, discovering and sharing knowledge," said Saeid Akhtari, NextBio President and Chief Executive Officer. "We are pleased that USC has chosen to join the growing number of leading academic, public and corporate research institutions that have made NextBio an integral part of their research efforts."

Source:

 NextBio

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy